Patent Assignment
Reel/Frame 064576/0399
Corrective Assignment to Correct the Assignment Document Previously Recorded on Reel 057326 Frame 0040. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2023-08-14
Pages: 7
Assignor
MANGUKIYA, HITESH BHAGAVANBHAI
Executed: 2021-08-17
Assignee
ANOVENT PHARMACEUTICAL (U.S.), LLC
ONE GATEWAY CENTER, SUITE 2600, NEWARK, NEW JERSEY, 07102
Covered Properties
(2)
Formulation of Tocilizumab and Method for Treating Covid-19 by Inhalation
Biopharmaceutical Formulation of Anti-Pd-1, Anti-Pd-L1, and Anti-Vegfr Therapeutic Monoclonal Antibodies and Method for Treating Nsclc by Inhalation
Application:
17/362,218 →
Publication:
US 2021/0403568
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 30, 2021
From: MANGUKIYA, HITESH BHAGAVANBHAI
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0040 →
Assignment of Assignor's Interest
Aug 30, 2021
From: HUANG, CAI GU
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 057326/0322 →
Change of Name
Jun 13, 2023
From: ANOVENT PHARMACEUTICAL (U.S.), LLC
To: ANOBRI PHARMACEUTICALS US, LLC
Reel/Frame 063983/0307 →
Corrective Assignment to Correct the Assignment Document Previously Recorded at Reel: 057326 Frame: 0322. Assignor(S) Hereby Confirms the Assignment.
Aug 14, 2023
From: HUANG, CAI GU
To: ANOVENT PHARMACEUTICAL (U.S.), LLC
Reel/Frame 064576/0500 →